Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

TP53 mutation is not an independent prognostic factor in patients with mantle cell lymphoma at advanced stage.

Medical oncology (Northwood, London, England) - 1 Sept 2012

Dong Hua-Jie, Zhou Li-Tao, Fang Cheng, Fan Lei, Zhu Dan-Xia, Wang Yin-Hua, Li Jian-Yong, Xu Wei

Abstract excerpt

Mantle cell lymphoma (MCL) is incurable in most patients. Several molecular markers have been identified as possible prognostic factors in MCL, including TP53 mutations. Direct sequencing was used to detect 32 cases with leukemic presentation of MCL form exons 2-11 in order to explore the prognostic significance of TP53 mutations in Chinese patients. Within the MCL cohort, 6(18.8%) patients harbored TP53...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Flow Cytometry
Share to In Situ Hybridization, Fluorescence

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Kaplan-Meier Estimate

Share to Lymphoma, Mantle-Cell

Share to Neoplasm Staging

Share to Prognosis

Share to Proportional Hazards Models

Share to Tumor Suppressor Protein p53

Source

Identifiers

PMID: 22057359
DOI: 10.1007/s12032-011-0096-5

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026. Manifest publication-graph-cohort-2026-09-05.1.

Source receipt: pubmed, retrieved 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

TP53 mutation is not an independent prognostic factor in patients with mantle cell lymphoma at advanced stage.PMID 22057359Read ↗

TP53 mutation heterogeneity reveals distinct prognoses in mantle cell lymphoma.Semantic proximity Read ↗

TP53 mutations identify younger mantle cell lymphoma patients who do not benefit from intensive chemoimmunotherapy.Semantic proximity Read ↗

p53 immunohistochemistry must be confirmed by TP53 next generation sequencing for accurate risk stratification of patients with mantle cell lymphoma.Semantic proximity Read ↗

p53 is associated with high‐risk and pinpointsTP53missense mutations in mantle cell lymphomaSemantic proximity Read ↗

ATM and TP53 mutations show mutual exclusivity but distinct clinical impact in mantle cell lymphoma patientsSemantic proximity Read ↗

Absence of CD38 expression in mantle cell lymphoma correlates with distinct pathological and genetic features.Semantic proximity Read ↗

Complex analysis of the TP53 tumor suppressor in mantle cell and diffuse large B-cell lymphomas.Semantic proximity Read ↗

[Research advance of p53 gene in mantle cell lymphoma].Semantic proximity Read ↗

Loss of the p53 tumor suppressor activity is associated with negative prognosis of mantle cell lymphoma.Semantic proximity Read ↗

TP53 mutation and survival in aggressive B cell lymphoma.Semantic proximity Read ↗

Prognostic Value and Computer Image Analysis of p53 in Mantle cell LymphomaSemantic proximity Read ↗

TP53 Mutation and Complex Karyotype Portends a Dismal Prognosis in Patients With Mantle Cell Lymphoma.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.